Tag: Cancer: Skin
USPSTF: Evidence Still Lacking for Routine Skin Cancer Screening
Current evidence is insufficient for assessing balance of benefits and harms of screening for asymptomatic teens, adults
Nivolumab Promising for Treatment of Advanced Cutaneous SCC
Robust antitumor activity and good tolerability observed in phase 2 study of nivolumab for first-line treatment of advanced cutaneous squamous cell carcinoma
Treatment Sequence Studied for Advanced BRAF-Mutant Melanoma
Two-year overall survival higher for those initiating treatment with combo nivolumab/ipilimumab versus dual BRAF/MEK inhibition
Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC
In phase 2 study, about half of patients with resectable stage II to IV cutaneous squamous cell carcinoma had pathological complete response
Global Disease Burden Related to Nonmelanoma Skin Cancer Explored
Number of new cases, deaths, and DALYs attributable to NMSC expected to increase at least 1.5-fold by 2044
Prior Diagnoses Influence Dermatopathologists’ Interpretations
Prior diagnoses swayed dermatopathologists from correct diagnosis to incorrect diagnosis in the interpretation of melanocytic lesions
Actinic Keratosis Diagnosed in Almost One-Third of Older Adults
Authors say increased use of topical fluorouracil may be warranted
Pregnancy Does Not Affect Survival in Women With Melanoma
Racial and socioeconomic factors linked to melanoma survival in women of childbearing age
Higher Fish Intake May Increase Melanoma Risk
Higher total fish intake, tuna intake, nonfried fish intake positively linked to risks of malignant melanoma, melanoma in situ
ASCO: Desmoplastic Melanoma Responds to Neoadjuvant Pembrolizumab
Fifty-six percent of patients had pathologic complete response after neoadjuvant treatment with pembrolizumab
